Blog Posts by Author: Joe Nollar
Introducing XIFIN LIS 8: Helping Your Laboratory Scale and Respond to Changing Market Demands
We recently introduced the newest iteration of our cloud-based laboratory information system (LIS), XIFIN LIS 8. This is yet another example of our continued commitment and investment toward improving operational, clinical and financial outcomes for diagnostic providers.XIFIN LIS 8 introduces several new capabilities informed by customer and market input. For example, earlier this year we...
You Invested to Meet the Demand for COVID-19 Testing: How Do You Optimize that Investment Post-Pandemic?
At the beginning of the COVID-19 pandemic in the U.S., many laboratories invested in equipment, supplies, and personnel to manage the surge of COVID-19 test demand. For the laboratory information system (LIS), the backbone of the laboratory IT infrastructure, this meant new workflows, report templates, and instrument interfaces to handle the new COVID-19 Polymerase Chain Reaction (PCR) tests.Once...
University of Southern California (USC) Department of Pathology and Laboratory Medicine — An Outreach Success Story
The University of Southern California (USC) Department of Pathology and Laboratory Medicine is one of the largest and most acclaimed in the country, with nationally and internationally renowned physicians on its staff. When the team at USC decided to open an outreach laboratory to expand their lab services to the community, the department chose XIFIN, Inc. as its pathology laboratory information...
XIFIN LIS Keeps Laboratories Nimble: Responding Quickly to Fluctuations in COVID-19 Testing Demand and Turnaround Times
Early in the COVID-19 pandemic, laboratories were focused on the capabilities needed to get them ramped up quickly to handle COVID-19 testing. As 2020 wore on, labs were challenged to keep up with significant fluctuations in COVID testing volume, as well as ongoing shortages in test supplies.In October 2020, the Centers for Medicare & Medicaid Services (CMS) announced that starting January 1...
Digital Pathology Trends and the Impact of COVID-19 on Speed of Adoption
Digital pathology was introduced decades ago as a way for sharing digital images across laboratories, enabling pathologists to work together on cases and enhance the accuracy of diagnostic techniques. Before the COVID-19 pandemic, U.S. adoption of digital pathology lagged behind most other developed countries.The COVID-19 pandemic accelerated the adoption of digital pathology in this country for...
Balancing the 4 C’s of Laboratory Information Systems – Cost, Complexity, Control, and Change
Deciding which LIS is best suited to meet the needs of your laboratory today and in the future is an important decision with several factors to be considered. No LIS is fully “plug-and-play”; some configuration is always required. The question is how much, and whether it is implemented with the tools and templates provided by the software vendor, in order to avoid becoming a one-off...
Digital Pathology Primary Diagnosis is Approved – Is Your Lab Ready for the Future?
Earlier this month, there was an exciting announcement that Leica received their FDA 510(k) clearance to market a digital pathology whole slide imaging system for primary diagnosis. This comes on the heels of Philips’ groundbreaking announcement of FDA clearance in late 2017, which was the first device ever cleared for primary diagnosis. These advancements are initiating significant momentum in...
- ‹ previous
- 2 of 2